Position
Optas, LLC in Gilead Sciences, Inc.
Back to the book · All holders of GILD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $62.8K$122.74 → $139.37
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.77K | $463.3K | — | — | — | 0.1% |
| Q1 2026 | 4.13K | $575K | $139.37 | $62.8K | $48.9K | 0.1% |